As of 2025-07-08, the Gross Margin of Molecular Pharmacology (USA) Ltd (MLPH) is 7775.2%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2016-06-30 | 7775.2% |
2015-06-30 | - |
2014-06-30 | - |
2013-06-30 | - |
2012-06-30 | - |
2011-06-30 | - |
2010-06-30 | - |
2009-06-30 | - |
2008-06-30 | - |
2007-06-30 | - |